Milestone Scientific, Inc.

145 articles with Milestone Scientific, Inc.

• Milestone Scientific Inc. Awarded Group Purchasing Agreement with Premier for CompuFlo® Epidural System

  10/13/2020

  Milestone Scientific Inc. (NYSE American:MLSS ), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, today announced that it has been awarded a group purchasing agreement for the CompuFlo® Epidural System and CathCheck™ with Premier. Effective November 1, 2020, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-n

• Milestone Scientific Inc. Projects Over Five-Fold Sequential Increase in Dental Sales for Q3 2020 Versus Q2 2020

  10/1/2020

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provides painless and precise injections, announced that it projects sales for the third quarter ending September 30, 2020 increased sequentially more than five-fold versus the second quarter ending June 30, 2020.

• Milestone Scientific to Hold Investor Webinar and Q&A Session with CEO on September 14

  9/10/2020

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provides painless and precise injections, announced that Leonard Osser, Interim Chief Executive Officer, will share insight into the company's recent developments and upcoming milestones during an investor webinar on Monday, September 14, 2020 at 4:00 p.m. ET.

• Milestone Scientific Reports Increasing Dental Sales and Robust Pipeline for CompuFlo(R) Epidural System and CathCheck(TM)

  9/9/2020

  Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update regarding the Company's Wand® dental business, as well as the commercial roll-out of its CompuFlo® Epidural System and CathCheck™ technology.

• Milestone Scientific Promotes Arjan Haverhals to President of Milestone Scientific

  9/1/2020

  Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has promoted Jan Adriaan (Arjan) Haverhals to President of Milestone Scientific, replacing Brent Johnston.

• Milestone Scientific to Present at The LD 500 Virtual Conference on September 1st

  8/27/2020

  Milestone Scientific Inc. today announced that it will be presenting at The LD 500 Investor conference being held virtually on September 1-4, 2020.

• Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2020

  8/17/2020

  Milestone Scientific Inc. (NYSE:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter and six months ending June 30, 2020.

• Milestone Scientific Schedules Second Quarter 2020 Conference Call

  8/13/2020

  Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, August 17, 2020 to discuss the Companys financial results for the second quarter ended June 30, 2020, as well as the Companys corporate progress and other developments.

• Milestone Scientific Inc. today announced that on June 30, 2020 it closed its previously announced underwritten offering of 6,520,000 shares of its common stock

  6/30/2020

  Milestone Scientific Inc. today announced that on June 30, 2020 it closed its previously announced underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of the its common stock. Each share of common stock was sold together with a warrant to purchase 0.5

• Milestone Scientific Company Update

  6/30/2020

  Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that on June 30, 2020 it closed its previously announced underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of the its common stock. Each share of common stock was sold together with a warrant to purchase 0.5

• Milestone Scientific Announces Pricing of $14.0 Million Offering of Common Stock and Warrants

  6/25/2020

  Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today the pricing of an underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of its common stock.

• Milestone Scientific CEO Steps Down Months After Taking Job, Interim Leader Named

  10/6/2017

• Milestone Scientific Names a New CEO

  7/11/2017

• Milestone Scientific Snags 510(k) FDA Clearance for Epidural Anesthesia System

  6/13/2017

• Milestone Scientific Announces Regulatory Marketing Clearance To Sell Epidural And Intra-Articular Instruments And Disposables In Australia

  4/4/2017

• Milestone Scientific Schedules 2016 Year-End Earnings Conference Call

  4/3/2017

• FDA Denies Milestone Scientific’s Compu-Flo 510(K) Application

  12/16/2016

• Milestone Scientific Inks Exclusive Distribution Pact With Henry Schein

  6/29/2016

• Milestone Scientific Forms Global Advisory Board In Advance Of The Finalization Of The 400 Patient Clinical Study

  2/19/2016

• Milestone Scientific's Epidural & Intra-Articular Subsidiary Announces Abstract Acceptance For Presentation At The Euroanaesthesia 2016 Congress

  2/11/2016